1. Home
  2. CORT vs MXL Comparison

CORT vs MXL Comparison

Compare CORT & MXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

SELL

Current Price

$113.79

Market Cap

9.7B

Sector

Health Care

ML Signal

SELL

Logo MaxLinear Inc.

MXL

MaxLinear Inc.

HOLD

Current Price

$86.31

Market Cap

8.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CORT
MXL
Founded
1998
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.5B
IPO Year
2001
2009

Fundamental Metrics

Financial Performance
Metric
CORT
MXL
Price
$113.79
$86.31
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$96.50
$41.67
AVG Volume (30 Days)
823.3K
2.1M
Earning Date
04-30-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
46.08
EPS
0.09
N/A
Revenue
$761,407,000.00
$478,596,000.00
Revenue This Year
$26.08
$22.10
Revenue Next Year
$26.98
$10.70
P/E Ratio
$1,224.56
N/A
Revenue Growth
12.79
N/A
52 Week Low
$28.66
$12.77
52 Week High
$126.38
$128.30

Technical Indicators

Market Signals
Indicator
CORT
MXL
Relative Strength Index (RSI) 52.88 64.22
Support Level $108.25 $79.18
Resistance Level $124.30 $89.00
Average True Range (ATR) 5.29 4.59
MACD -0.76 2.60
Stochastic Oscillator 61.04 92.83

Price Performance

Historical Comparison
CORT
MXL

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

Share on Social Networks: